ProImmune Ltd has launched a new Special Assay Service, providing unique, bespoke immunological assays, based on ProImmune’s broad ranging proprietary platform technologies, to meet customers’ assay needs.

ProImmune has developed the service in response to increasing demand for modified versions of the company’s growing range of immunology platform assays, to suit particular needs. In many cases ProImmune’s standard assays can be readily adapted to meet the customer’s requirements, and therefore deployed rapidly, enabling fast implementation of unique protocols that could otherwise take months or years to develop and qualify in house.

ProImmune’s existing immunology assay services include immune modulation assays, managing drug immunogenicity risk, characterising the immune response to new antigens, and a wide range of immune monitoring assays.

Source: ProImmune